Key Points
(Reuters) -AstraZeneca has warned it could relocate its vaccine manufacturing site from the UK to the U.S. amid a deadlock with the new Labour government over plans to cut state aid, the Financial Times reported on Thursday...
British finance minister Rachel Reeves wants to reduce state provisions to the vaccine centre, which will cut the pledge made by the previous administration from about 90 million pounds to 40 million pounds, the report said, citing sources...
The previous offer included up to 70 million in grants to develop a facility in Speke, Liverpool and 20 million pounds in research and development support from the UK Health Security Agency, per FT...
The Sunak administration in March planned to invest 650 million pounds in the Anglo-Swedish drugmaker to boost research, development and manufacturing of vaccines...
You might be interested in
AstraZeneca warns of moving UK vaccine production to US, FT reports
23, Aug, 24(Reuters) -AstraZeneca has warned it could relocate its vaccine manufacturing site from the UK to the U.S. amid a deadlock with the new Labour government over plans to cut state aid, the Financial
AstraZeneca Pharma India plans to sell Bengaluru plant
16, Nov, 23The company will position the manufacturing site for sale in a fully operational manner and begin a search for a buyer who can also act as a contract manufacturing organisation (CMO) for its products currently manufactured or packaged at the site, subject to receipt of necessary statutory approvals, the drug firm said.
Karnataka govt clears Foxconn mobile manufacturing unit proposal for Rs 8,000cr
20, Mar, 23India Business News: BENGALURU: The Karnataka government on Monday in its state high level clearance committee (SHLCC) cleared the big ticket investment of Taiwanese based.
AstraZeneca to invest $245 mln in Cellectis to boost gene therapy prospects
01, Nov, 23AstraZeneca (AZN.L) said on Wednesday it would invest $245 million in French biotechnology company Cellectis (ALCLS.PA) in a deal aimed at speeding up the development of therapeutics in areas including oncology, immunology and rare diseases.
US slams India on human rights practices in its annual report
21, Mar, 23In an annual report on human rights practices in India, the United States State Department has highlighted challenges to freedom of expression, cases of arbitrary arrests and detentions, extrajudicial killings, the confiscation and destruction of property without due process, discrimination against minority groups and infringement on the freedom of association, among other issues, in 2022. | Latest News India
Explained: Why AstraZeneca has decided to withdraw its Covid vaccine globally
08, May, 24AstraZeneca had recently admitted in court documents that its vaccine against Covid-19 has the potential to cause TTS, a rare side effect associated with blood clotting.
Avaya to invest, hire more people in India, says CEO
12, May, 23The company, which is involved in multiple public sector programmes in the country, will also invest to support India's ambitious initiatives such as self-reliance.
Covid vaccine mission is a lesson for the world
27, Feb, 23Not only did India succeed in protecting its population, but it also sent vaccines to other countries, thus proving to the world its capability of developing the first-ever DNA vaccine and nasal drop vaccine within two years
Berkshire Hathaway exits India's Paytm in $165 million deal
24, Nov, 23BENGALURU (Reuters) - Berkshire Hathaway has exited India's Paytm after selling its entire stake in the company for about 13.71 billion rupees ($164.70 million) through a bulk deal on Friday.